OCM™ Wound Matrix is an anhydrous acellular matrix. It is a drug-device product delivering multimodal therapy to address all phases of wound healing.
INTENDED USES: OCM™ Wound Matrix is indicated for the management of wounds including: partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/grafts, post-Moh’s surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, superficial partial thickness burns, skin tears) and draining wounds.
CLAIMED BENEFITS: Addresses all phases of wound healing, Use on wounds head to toe, Use on variety of wound etiologies, Typical application frequency is once a week, Room temperature storage, No additional product preparation required, Migrates into tunnels and crevices of wound bed
OPTIONS: Per 100 mg
Wound Reference does not produce, market, re-sell or distribute health care goods or services consumed by, or used on, patients.
